TRACON Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCON and other ETFs, options, and stocks.About TCON
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma.
CEOCharles P. Theuer
CEOCharles P. Theuer
Employees17
Employees17
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2004
Founded2004
Employees17
Employees17
TCON Key Statistics
Market cap4.82M
Market cap4.82M
Price-Earnings ratio-0.44
Price-Earnings ratio-0.44
Dividend yield—
Dividend yield—
Average volume446.87K
Average volume446.87K
High today$2.34
High today$2.34
Low today$2.05
Low today$2.05
Open price$2.09
Open price$2.09
Volume351.92K
Volume351.92K
52 Week high$41.00
52 Week high$41.00
52 Week low$1.59
52 Week low$1.59